Nexien BioPharma, Inc (OTC: NXEN) Developing a cannabinoid-based drug pipeline.

November 14, 2018 admin CEO Interview, Healthcare Comments Off on Nexien BioPharma, Inc (OTC: NXEN) Developing a cannabinoid-based drug pipeline.
Alex Wasyl, CEO Nexien BioPharma

 

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

 

 

Alex Wasyl, CEO Nexien BioPharma

 

 

 

 

 

 

Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.




Related Articles

Newsmakers

Yield Growth (OTC: BOSQF) Files PCT Patent for Cannabis Root Extraction Method for Key Ingredient in 150 Proprietary Beauty and Wellness Formulas

April 17, 2019 admin Newsmakers Comments Off on Yield Growth (OTC: BOSQF) Files PCT Patent for Cannabis Root Extraction Method for Key Ingredient in 150 Proprietary Beauty and Wellness Formulas

VANCOUVER, British Columbia, April 16, 2019 — The Yield Growth Corp. CSE: BOSS) (OTC: BOSQF) (frankfurt:YG3) announces it has filed a patent application to protect its inventions for hemp root oil production and its use in […]

Consumer

American Premium Water Corp. (OTC: HIPH) Announces Sponsorship of NFL Draft Party Hosted by Star New York Jets Running Back Le’Veon Bell

April 30, 2019 admin Consumer, Newsmakers Comments Off on American Premium Water Corp. (OTC: HIPH) Announces Sponsorship of NFL Draft Party Hosted by Star New York Jets Running Back Le’Veon Bell

The event further establishes LALPINA CBD’s connection to professional athletes as the Company looks to penetrate the $30 billion US fitness market PLAYA VISTA, Apr 25, 2019  – American Premium Water Corporation(OTC: HIPH) announces that […]